International Biotechnology Trust PLC
Summary
International Biotechnology Trust (IBT) is an investment trust company listed on the London Stock Exchange which invests in companies within the biotechnology sector. The portfolio aims to capture the best chances of clinical, regulatory and commercial success from a diversified portfolio of public and private biotechnology investments.
Objective
To achieve long term capital growth by investing in high growth, development stage biotechnology companies that are either quoted or unquoted. IBT invests in shares of companies that are considered to be good value, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
| Top Ten Quoted Investments |
% NAV |
Country |
| Micromet |
9.3 |
USA |
| Celgene |
5.7 |
USA |
| Amgen |
5.5 |
USA |
| Gilead Sciences |
4.4 |
USA |
| Alexion Pharmaceuticals |
3.3 |
USA |
| Genzyme |
3.2 |
USA |
| Affymax |
3.0 |
USA |
| Wright Medical |
2.9 |
USA |
| EV3 |
2.8 |
USA |
| Halozyme Therapeutics |
2.8 |
USA |
| Total |
42.9 |
|
| 31st August 2009 |
| Unquoted Investments |
Country |
| Affinium Pharmaceuticals |
USA |
| Allocure |
USA |
| Archemix |
USA |
| Archemix |
USA |
| Cadent |
USA |
| CR |
USA |
| Dynogen |
USA |
| EBR Systems |
USA |
| Entellus Medical |
USA |
| ESBATech |
Switzerland |
| EUSA Pharmaceuticals |
UK |
| Ikano Therapeutics |
USA |
| Itero Pharmaceuticals |
USA |
| Lux Biosciences |
USA |
| Oxagen |
UK |
| Reshape Medical |
USA |
| RespiVert |
UK |
| Ricerca |
USA |
| Spinal Kinetics |
USA |
| Sutro Biopharma |
USA |
| TransEnterix |
USA |
| Vantia |
UK |
| 31st August 2009 |
|
0.00p
